SOUTH KINGSTOWN – Dr. Anne S. De Groot, founder of EpiVax Inc. and a professor at the College of the Environmental and Life Sciences at the University of Rhode Island, was the recipient of a Distinguished Service Award from the University of Chicago, her alma mater, earlier this summer.
A member of the Class of 1983 at the Pritzker School of Medicine at the University of Chicago, De Groot was highlighted by the school’s Medical & Biological Sciences Alumni Association. She was recognized for her dedication to health care and a “genomes-to-vaccines” focus on solving infectious diseases across the globe.
How the Fastest Growing and Most Innovative Companies Utilize Technology for Their Success
As the Managing Director of RIHub, Rhode Island’s Innovation Hub, I have the privilege of…
Learn More
De Groot, the author of more than 200 peer-reviewed publications, is the founder, CEO and chief science officer of EpiVax.
Over the past 35 years since graduating from the University of Chicago medical school, she has worked in the field vaccinating against measles in the Congo, performed nutrition surveys in the Soweto and Alexandra townships of Johannesburg in the Gauteng province of South Africa and researched the malaria vaccine impact in The Gambia. She has travelled many times to Mali and parts of West Africa with the GAIA Vaccine Foundation to promote vaccinations and vaccination acceptance among communities there.
Emily Gowdey-Backus is a staff writer for PBN. You can follow her on Twitter @FlashGowdey or contact her via email, gowdey-backus@pbn.com.
